Bio-Rad Reports Third-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Bio-Rad Labs (BIO) Tops Q3 EPS by $1.20
October 29, 2020 4:20 PM EDTBio-Rad Labs (NYSE: BIO) reported Q3 EPS of $3.00, $1.20 better than the analyst estimate of $1.80. Revenue for the quarter came in at $647.3 million versus the consensus estimate of $570.58 million.
2020 Financial Outlook:
The company currently believes that full-year 2020 year-over-year currency-neutral sales... More
